Dermatology & Skin Care

Diclofenac Gel 1.16% (Diclofenac Diethylamine) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.

Adapalene (0.1% w/w gel) is a third-generation synthetic retinoid on the WHO Model List of Essential Medicines. It selectively modulates cellular differentiation and keratinization by binding to retinoic acid receptors beta and gamma, inhibiting microcomedone formation and down-regulating inflammatory lipoxygenase pathways. Exhibits greater chemical stability and lower cutaneous irritation than tretinoin. Indicated for the topical treatment of acne vulgaris.

Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.

Beclomethasone 0.025% and Neomycin 0.5% Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Calamine lotion (Zinc Oxide and Ferric Oxide with Aloe Vera and Light Liquid Paraffin) is a classic topical soothing astringent and antipruritic on the WHO Model List of Essential Medicines. It evaporates to cool the skin, while zinc oxide provides mild antiseptic and protective barrier coverage. Indicated for symptomatic relief of itching, insect bites, sunburn, chickenpox rash, poison ivy, and prickly heat.

Clobetasol Propionate (0.05% w/w) is an ultra-high potency (Class I) topical synthetic corticosteroid on the WHO Model List of Essential Medicines. It binds to intracellular glucocorticoid receptors, down-regulating inflammatory cytokines (IL-1, IL-2, TNF-alpha) and inducing lipocortins to block phospholipase A2 and arachidonic acid cascade products. Indicated for short-term management of moderate-to-severe plaque psoriasis, recalcitrant dermatoses, lichen planus, and severe discoid lupus erythematosus.

Fusidic Acid (2% w/w cream) is a steroid-like antibacterial agent that inhibits bacterial protein synthesis by interfering with elongation factor G (EF-G) on the ribosome. Highly active against Staphylococcus aureus, including methicillin-resistant strains (MRSA) and Corynebacterium species. Penetrates intact skin effectively. Indicated for impetigo, folliculitis, erythrasma, furunculosis, and infected wounds.

Ketoconazole topical cream (2% w/v) is a broad-spectrum imidazole antifungal agent. It disrupts fungal cell membranes by inhibiting 14-alpha-demethylase, eradicating dermatophytes, Candida species, and Malassezia yeasts. Indicated for tinea corporis, tinea cruris, tinea pedis, cutaneous candidiasis, and pityriasis versicolor.

Povidone Iodine Ointment 5% w/w is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Povidone Iodine Ointment 5% w/w is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Povidone-Iodine Solution 10 % w/v is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Povidone-Iodine Solution 5 % w/v is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Povidone Iodine Solution 7.5% w/v is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Silver Sulphadiazine 1% , Chlorhexidine Gluconate 0.2% , Allantoin 0.1% , Aloe vera 15% Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Silver Sulphadiazine 1% , Chlorhexidine Gluconate 0.2% , Allantoin 0.1% , Aloe vera 15% Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Hydroquinone, Tretinoin, and Fluocinolone Acetonide is the gold-standard Triple Combination Cream (Kligman's formula) for refractory melasma. Hydroquinone (2-4%) competitively inhibits tyrosinase, blocking melanin pigment synthesis; Tretinoin (0.05%) accelerates epidermal turnover and keratinocyte shedding, facilitating hydroquinone penetration and dispersing melanin; and Fluocinolone Acetonide (0.01%), a mild-to-moderate topical corticosteroid, suppresses melanocyte inflammation and counteracts the irritant dermatitis of hydroquinone and tretinoin. Indicated for the short-term moderate-to-severe melasma of the face.

Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.

Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.

Mupirocin (2% w/w ointment) is a naturally derived antibiotic produced by Pseudomonas fluorescens on the WHO Model List of Essential Medicines. It reversibly binds specifically to bacterial isoleucyl-tRNA synthetase, completely arresting RNA and protein synthesis with zero cross-resistance to other antibiotic classes. Displays potent bactericidal activity against MRSA, MSSA, and Streptococcus pyogenes. Indicated for impetigo, traumatic skin lesions secondarily infected by S. aureus, and eradication of nasal MRSA carriage.

Diclofenac 1.16%, Linceed Oil 3%, Methyl Salicylate 10% and Menthol 5% Gel is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.

Silver Nitrate 0.20% and Chlorhexidine Gluconate 0.20% Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Povidone-Iodine Powder 5% W/W is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Paradichlorobenzene 2%, Benzocaine 2.7%, Chlorbutol 5% and Turpentine Oil 15% Ear Drops is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Ketoconazole (2% w/v, alone or with Zinc Pyrithione 1%) is a topical imidazole broad-spectrum antifungal shampoo. It targets Malassezia furfur (Pityrosporum ovale), the lipophilic yeast implicated in seborrheic dermatitis and pityriasis capitis (dandruff), by inhibiting fungal ergosterol synthesis and reducing scalp scaling, erythema, and pruritus. Indicated for seborrheic dermatitis, stubborn dandruff, and pityriasis (tinea) versicolor of the scalp and trunk.

Adapalene (0.1% w/w gel) is a third-generation synthetic retinoid on the WHO Model List of Essential Medicines. It selectively modulates cellular differentiation and keratinization by binding to retinoic acid receptors beta and gamma, inhibiting microcomedone formation and down-regulating inflammatory lipoxygenase pathways. Exhibits greater chemical stability and lower cutaneous irritation than tretinoin. Indicated for the topical treatment of acne vulgaris.

Clobetasol Propionate (0.05%) combined with antibacterial (Gentamicin/Neomycin) and/or antifungal (Miconazole) agents. Delivers rapid anti-inflammatory and anti-pruritic relief while providing broad-spectrum coverage against secondary bacterial and candidal/dermatophyte infections in steroid-responsive dermatoses. Indicated for infected inflammatory dermatoses, infected eczema, and severe intertrigo.

Nimesulide Gel 1% is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Diclofenac Dithylamine 1.16%, Linseed Oil 3%, Methyl Salicylate 10% and Menthol 5% Spray is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Chlorhexidine Gluconate 0.3%v/v + Cetrimide 0.6%w/v Antiseptic Liquid is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Gama Benzene Hexachloride 1% and Cetrimide 0.1% lotion is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Mometasone Furoate (0.1% w/w cream/ointment) is a high-potency (Class II) synthetic topical corticosteroid on the WHO Model List of Essential Medicines. It features a high therapeutic index, providing robust anti-inflammatory and anti-pruritic activity with significantly lower systemic absorption and cutaneous atrophogenic potential than older fluorinated steroids. Indicated for relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, including atopic dermatitis and psoriasis.

Glycerin 98% is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.

Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.

Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.

Bacitracin 250 IU, Neomycin 5mg, Sulphacetamide 60mg Dusting Powder is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Isopropyl Alcohol (70%) (Spirit) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Ketoconazole topical cream (2% w/v) is a broad-spectrum imidazole antifungal agent. It disrupts fungal cell membranes by inhibiting 14-alpha-demethylase, eradicating dermatophytes, Candida species, and Malassezia yeasts. Indicated for tinea corporis, tinea cruris, tinea pedis, cutaneous candidiasis, and pityriasis versicolor.

Fluocinolone Acetonide / Fluocinonide is an intermediate-to-high potency fluorinated topical corticosteroid. It suppresses cutaneous inflammation and capillary permeability. Indicated for atopic dermatitis, severe contact dermatitis, and lichenified eczema.

Permethrin (5% w/w cream/lotion or 1% soap) is a synthetic pyrethroid neurotoxic pediculicide and scabicide on the WHO Model List of Essential Medicines. It binds to voltage-gated sodium channels in the nerve membranes of arthropods (Sarcoptes scabiei mites, Pediculus humanus lice), delaying channel repolarization, causing persistent sodium influx, paralysis, and death of the parasites and their ova. Indicated for the treatment of scabies infestation and head/pubic lice.

Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.

Hand Sanitizer 100 ml (Each pack contains: Ethanol 70% v/v + Chlorhexidine Gluconate 0.5% w/v) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Hand Sanitizer 500 ml (Each pack contains: Ethanol 70% v/v + Chlorhexidine Gluconate 0.5% w/v) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Hand Sanitizer 250 ml (Each pack contains: Ethanol 70% v/v + Chlorhexidine Gluconate 0.5% w/v) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Selenium Sulphide Shampoo 2.5% is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Acitretin is an oral second-generation aromatic retinoid and the active acid metabolite of etretinate on the WHO Model List of Essential Medicines. It modulates cellular differentiation and proliferation in the epidermis, suppressing epidermal hyperkeratosis and parakeratosis. Indicated for severe extensive plaque psoriasis, pustular psoriasis, erythrodermic psoriasis, and severe disorders of keratinization (ichthyosis, Darier's disease).

Apremilast is an oral small-molecule phosphodiesterase 4 (PDE4) inhibitor on the WHO Model List of Essential Medicines. By inhibiting PDE4, it elevates intracellular cyclic adenosine monophosphate (cAMP), down-regulating pro-inflammatory cytokine expression (TNF-alpha, IL-17, IL-23) while up-regulating anti-inflammatory IL-10. Indicated for moderate-to-severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy, and active psoriatic arthritis.

Apremilast is an oral small-molecule phosphodiesterase 4 (PDE4) inhibitor on the WHO Model List of Essential Medicines. By inhibiting PDE4, it elevates intracellular cyclic adenosine monophosphate (cAMP), down-regulating pro-inflammatory cytokine expression (TNF-alpha, IL-17, IL-23) while up-regulating anti-inflammatory IL-10. Indicated for moderate-to-severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy, and active psoriatic arthritis.

Apremilast is an oral small-molecule phosphodiesterase 4 (PDE4) inhibitor on the WHO Model List of Essential Medicines. By inhibiting PDE4, it elevates intracellular cyclic adenosine monophosphate (cAMP), down-regulating pro-inflammatory cytokine expression (TNF-alpha, IL-17, IL-23) while up-regulating anti-inflammatory IL-10. Indicated for moderate-to-severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy, and active psoriatic arthritis.

Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.

Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.

Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.

Clindamycin and Nicotinamide topical gel is a dual-action anti-acne formulation. Clindamycin Phosphate (1% w/w) inhibits bacterial protein synthesis by binding to 50S ribosomes, eradicating Cutibacterium acnes, while Nicotinamide (4% w/w, Vitamin B3) exerts potent anti-inflammatory action by suppressing IL-8 and leukotriene-mediated neutrophil chemotaxis, reducing sebum production, and stabilizing the epidermal permeability barrier. Indicated for inflammatory acne vulgaris with papules and pustules.

Clobetasol Propionate (0.05%) combined with antibacterial (Gentamicin/Neomycin) and/or antifungal (Miconazole) agents. Delivers rapid anti-inflammatory and anti-pruritic relief while providing broad-spectrum coverage against secondary bacterial and candidal/dermatophyte infections in steroid-responsive dermatoses. Indicated for infected inflammatory dermatoses, infected eczema, and severe intertrigo.

Clobetasol Propionate (0.05%) combined with antibacterial (Gentamicin/Neomycin) and/or antifungal (Miconazole) agents. Delivers rapid anti-inflammatory and anti-pruritic relief while providing broad-spectrum coverage against secondary bacterial and candidal/dermatophyte infections in steroid-responsive dermatoses. Indicated for infected inflammatory dermatoses, infected eczema, and severe intertrigo.

Clobetasol Propionate (0.05%) combined with antibacterial (Gentamicin/Neomycin) and/or antifungal (Miconazole) agents. Delivers rapid anti-inflammatory and anti-pruritic relief while providing broad-spectrum coverage against secondary bacterial and candidal/dermatophyte infections in steroid-responsive dermatoses. Indicated for infected inflammatory dermatoses, infected eczema, and severe intertrigo.

Clobetasol Propionate (0.05%) and Salicylic Acid (3% or 6%) ointment is a potent keratolytic-corticosteroid combination for hyperkeratotic dermatoses. Clobetasol is an ultra-high potency (Class I) topical corticosteroid that produces rapid vasoconstriction, anti-inflammatory, and immunosuppressive actions, while salicylic acid dissolves the intercellular cement of the stratum corneum, desquamating thick adherent scales and enhancing the penetration of clobetasol into the dermis. Indicated for chronic plaque psoriasis, palmoplantar psoriasis, lichen planus, hypertrophic lichen simplex chronicus, and severe hyperkeratotic eczema.

Clobetasol Propionate (0.05%) and Salicylic Acid (3% or 6%) ointment is a potent keratolytic-corticosteroid combination for hyperkeratotic dermatoses. Clobetasol is an ultra-high potency (Class I) topical corticosteroid that produces rapid vasoconstriction, anti-inflammatory, and immunosuppressive actions, while salicylic acid dissolves the intercellular cement of the stratum corneum, desquamating thick adherent scales and enhancing the penetration of clobetasol into the dermis. Indicated for chronic plaque psoriasis, palmoplantar psoriasis, lichen planus, hypertrophic lichen simplex chronicus, and severe hyperkeratotic eczema.

Clobetasol Propionate (0.05%) combined with antibacterial (Gentamicin/Neomycin) and/or antifungal (Miconazole) agents. Delivers rapid anti-inflammatory and anti-pruritic relief while providing broad-spectrum coverage against secondary bacterial and candidal/dermatophyte infections in steroid-responsive dermatoses. Indicated for infected inflammatory dermatoses, infected eczema, and severe intertrigo.

Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.

Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.

Framycetin Sulphate (1% w/w cream) is a broad-spectrum aminoglycoside bactericidal antibiotic. It binds to the 30S ribosomal subunit of susceptible bacteria, inhibiting protein synthesis. Active against Staphylococcus aureus, Pseudomonas aeruginosa, and coliform bacteria. Indicated for treatment of superficial skin infections, burns, scalds, ulcers, cuts, abrasions, and impetigo.

Betamethasone Valerate / Dipropionate is a potent topical corticosteroid on the WHO Model List of Essential Medicines. It suppresses cutaneous inflammatory edema, erythema, and pruritus in eczema, psoriasis, and severe contact dermatitis. Often formulated in combination with Fusidic Acid, Gentamicin, or Miconazole to treat secondarily infected dermatoses.

Tretinoin (all-trans retinoic acid) is a topical retinoid on the WHO Model List of Essential Medicines. It binds to nuclear retinoic acid receptors (RAR), modifying gene expression to decrease follicular epithelial cohesiveness, stimulating mitotic turnover of follicular epithelial cells, expelling existing comedones, and preventing new microcomedone formation. Indicated for topical treatment of acne vulgaris and photoaged skin (fine facial wrinkles).

Ketoconazole topical cream (2% w/v) is a broad-spectrum imidazole antifungal agent. It disrupts fungal cell membranes by inhibiting 14-alpha-demethylase, eradicating dermatophytes, Candida species, and Malassezia yeasts. Indicated for tinea corporis, tinea cruris, tinea pedis, cutaneous candidiasis, and pityriasis versicolor.

Minoxidil topical solution (5% w/v) is a vasodilator and hair growth stimulant on the WHO Model List of Essential Medicines. It shortens the telogen (resting) phase, induces early entry into anagen (growth), increases hair follicle diameter, and enhances microvascular blood flow to the follicular papilla. Indicated for the treatment of androgenetic alopecia (pattern baldness) in men and women.

Minoxidil (5%) and Finasteride (0.1%) topical solution is an advanced dual-action therapy for male androgenetic alopecia (male pattern baldness). Minoxidil stimulates dermal papilla vascular endothelial growth factor (VEGF), opens potassium channels, and prolongs the anagen (growth) phase of hair follicles, while topical finasteride selectively inhibits type II 5-alpha reductase in the scalp, lowering local dihydrotestosterone (DHT) levels by up to 70% with substantially less systemic exposure than oral finasteride. Indicated for male androgenetic alopecia of the vertex and anterior scalp.

Janaushadhi Mosquito Repellent Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Neomycin 3400IU, Polymyxin B Sulfates 5000IU and Bacitracin Zinc 400IU Ophthalmic Ointment is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Coal Tar, Dithranol (Anthralin), and Salicylic Acid ointment is a classic triple keratoplastic and anti-mitotic anti-psoriatic compound. Coal tar exerts anti-proliferative and anti-pruritic actions; dithranol inhibits mitochondrial DNA synthesis in hyperplastic keratinocytes; and salicylic acid provides keratolysis. Indicated for subacute and chronic plaque psoriasis of the body and scalp.

Tacrolimus (0.03%, 0.1% ointment) is a topical calcineurin inhibitor (TCI) and non-steroidal immunosuppressant on the WHO Model List of Essential Medicines. It binds to intracellular immunophilin FKBP-12, forming a complex that inhibits calcineurin phosphatase, preventing dephosphorylation of NF-AT and blocking transcription of pro-inflammatory cytokines (IL-2, IL-3, IL-4, IFN-gamma) in T-lymphocytes. Unlike steroids, it does not cause skin atrophy, telangiectasia, or collagen breakdown. Indicated for moderate-to-severe atopic dermatitis (eczema) in patients not adequately responsive to or intolerant of conventional topical therapies, especially on the face, neck, and flexures.

Terbinafine Hydrochloride topical formulation is a fungicidal allylamine antifungal. It inhibits squalene epoxidase in fungal cell membranes, causing rapid fungal cell death. Highly effective against dermatophytes (Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum). Indicated for tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm).

Aloe Vera 10% and Vitamin E 1% Moisturising Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Glycolic Acid (6%, 12% cream or face wash) is an alpha-hydroxy acid (AHA) derived from sugarcane. It weakens the cohesion of corneocytes in the lower stratum corneum, promoting gentle chemical exfoliation, stimulating dermal collagen synthesis, and accelerating cell turnover. Indicated for mild-to-moderate acne, photoaging, rough texture, post-acne hyperpigmentation, and keratosis pilaris.

Glycolic Acid (6%, 12% cream or face wash) is an alpha-hydroxy acid (AHA) derived from sugarcane. It weakens the cohesion of corneocytes in the lower stratum corneum, promoting gentle chemical exfoliation, stimulating dermal collagen synthesis, and accelerating cell turnover. Indicated for mild-to-moderate acne, photoaging, rough texture, post-acne hyperpigmentation, and keratosis pilaris.

Selenium Sulphide Shampoo 1% is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Halobetasol Propionate (0.05% w/w) is an ultra-high potency (Class I) fluorinated topical corticosteroid. It produces intense vasoconstriction, suppression of immune cell migration, and potent anti-inflammatory action in severe hyperkeratotic and inflammatory skin conditions. Indicated for plaque psoriasis and severe steroid-responsive dermatoses.

Chlorhexidine Gluconate 1% , Metronidazole 1% and Lidocaine 2% dental Gel is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Povidone Iodine Gargle 2% w/v is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Benzoyl Peroxide (2.5%, 5% gel or soap) is a non-antibiotic topical anti-acne bactericidal agent on the WHO Model List of Essential Medicines. Upon application, it decomposes to release benzoic acid and reactive free oxygen radicals that oxidize bacterial proteins, rapidly destroying Cutibacterium acnes in the pilosebaceous follicle without inducing bacterial resistance. Also possesses mild comedolytic and keratolytic properties. Indicated for mild-to-moderate acne vulgaris.

Bifonazole 1% Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Clobetasol Propionate (0.05% w/w) is an ultra-high potency (Class I) topical synthetic corticosteroid on the WHO Model List of Essential Medicines. It binds to intracellular glucocorticoid receptors, down-regulating inflammatory cytokines (IL-1, IL-2, TNF-alpha) and inducing lipocortins to block phospholipase A2 and arachidonic acid cascade products. Indicated for short-term management of moderate-to-severe plaque psoriasis, recalcitrant dermatoses, lichen planus, and severe discoid lupus erythematosus.

Tretinoin (all-trans retinoic acid) is a topical retinoid on the WHO Model List of Essential Medicines. It binds to nuclear retinoic acid receptors (RAR), modifying gene expression to decrease follicular epithelial cohesiveness, stimulating mitotic turnover of follicular epithelial cells, expelling existing comedones, and preventing new microcomedone formation. Indicated for topical treatment of acne vulgaris and photoaged skin (fine facial wrinkles).

Miconazole Nitrate Cream 2% is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Beclomethasone Dipropionate Rotacaps 200mcg is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Beclomethasone Dipropionate Rotacaps 400mcg is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.

Feracrylum (1% w/v gel, solution, mouthwash) is a polyacrylic biocompatible hemostatic and antimicrobial agent. It complexes with plasma proteins (specifically albumin) to form an artificial micro-thrombus barrier, stopping capillary oozing within minutes while exerting broad-spectrum bactericidal activity without tissue necrosis. Indicated for control of localized capillary bleeding, minor surgical wounds, burn dressing, oral mucositis, and antiseptic wound care.

Salicylic Acid 1% Foaming Facewash is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Salicylic Acid 3% powder is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Salicylic Acid 2% Foaming Facewash is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Adapalene and Benzoyl Peroxide is a synergistic dual-mechanism topical anti-acne formulation. Adapalene (0.1%), a third-generation synthetic naphthoic acid retinoid, binds selectively to nuclear retinoic acid receptors (RAR-beta and RAR-gamma) to normalize follicular epithelial desquamation and resolve microcomedones while exerting potent anti-inflammatory effects. Benzoyl Peroxide (2.5%) releases bactericidal reactive oxygen species that rapidly kill Cutibacterium acnes without inducing bacterial resistance, and provides mild keratolysis. Indicated for the topical treatment of acne vulgaris with both inflammatory papules/pustules and non-inflammatory comedones.

Nadifloxacin (1% w/w cream) is a synthetic broad-spectrum fluoroquinolone bactericidal antibacterial agent for topical dermatological use. It inhibits bacterial DNA gyrase (topoisomerase II), blocking bacterial DNA replication against Cutibacterium acnes, Staphylococcus epidermidis, and methicillin-resistant S. aureus (MRSA). Indicated for acne vulgaris, folliculitis, and superficial bacterial skin infections.

Hydrocortisone Acetate (1% w/w) is a low-potency (Class VII) topical corticosteroid on the WHO Model List of Essential Medicines. It represents the safest topical steroid for sensitive skin areas (face, intertriginous skin folds, groin) and pediatric patients, providing anti-inflammatory, anti-pruritic, and mild vasoconstrictive actions with minimal risk of skin thinning or systemic absorption. Indicated for mild eczema, facial dermatitis, intertrigo, insect bites, and anogenital pruritus.

Nadifloxacin (1% w/w cream) is a synthetic broad-spectrum fluoroquinolone bactericidal antibacterial agent for topical dermatological use. It inhibits bacterial DNA gyrase (topoisomerase II), blocking bacterial DNA replication against Cutibacterium acnes, Staphylococcus epidermidis, and methicillin-resistant S. aureus (MRSA). Indicated for acne vulgaris, folliculitis, and superficial bacterial skin infections.

Ketoconazole (2% w/v, alone or with Zinc Pyrithione 1%) is a topical imidazole broad-spectrum antifungal shampoo. It targets Malassezia furfur (Pityrosporum ovale), the lipophilic yeast implicated in seborrheic dermatitis and pityriasis capitis (dandruff), by inhibiting fungal ergosterol synthesis and reducing scalp scaling, erythema, and pruritus. Indicated for seborrheic dermatitis, stubborn dandruff, and pityriasis (tinea) versicolor of the scalp and trunk.

Amorolfine Hydrochloride (0.25% cream or 5% nail lacquer) is a morpholine-class broad-spectrum fungicidal agent. It inhibits two distinct sequential enzymes in fungal sterol biosynthesis: delta-14-reductase and delta-7,8-isomerase, depleting ergosterol and causing accumulation of atypical ignosterol in fungal membranes. Nail lacquer forms a non-water-soluble lacquer film that penetrates the nail plate to the nail bed, maintaining high antifungal concentrations for over a week. Indicated for distal and lateral subungual onychomycosis (without matrix involvement) and superficial dermatomycoses.

Azelaic Acid (10%, 20% cream) is a naturally occurring saturated dicarboxylic acid anti-acne and anti-rosacea agent. It inhibits DNA synthesis in Cutibacterium acnes, suppresses follicular hyperkeratinization (comedolytic), and competitively inhibits tyrosinase, reducing post-inflammatory hyperpigmentation without bleaching normal skin. Indicated for mild-to-moderate inflammatory acne vulgaris, papulopustular rosacea, and post-inflammatory hyperpigmentation/melasma.

Ciclopirox Olamine (1% cream or 8% nail lacquer) is a synthetic hydroxypyridone broad-spectrum antifungal with anti-inflammatory and antibacterial properties. Unlike azoles, it does not inhibit sterol synthesis; it acts by chelating trivalent cations (Fe3+, Al3+), inhibiting metal-dependent enzymes (cytochromes, catalase, peroxidase) in mitochondrial electron transport and cellular permeability. Indicated for onychomycosis of fingernails and toenails (lacquer), tinea pedis, tinea cruris, tinea corporis, and cutaneous candidiasis.

Ciclopirox Olamine (1% cream or 8% nail lacquer) is a synthetic hydroxypyridone broad-spectrum antifungal with anti-inflammatory and antibacterial properties. Unlike azoles, it does not inhibit sterol synthesis; it acts by chelating trivalent cations (Fe3+, Al3+), inhibiting metal-dependent enzymes (cytochromes, catalase, peroxidase) in mitochondrial electron transport and cellular permeability. Indicated for onychomycosis of fingernails and toenails (lacquer), tinea pedis, tinea cruris, tinea corporis, and cutaneous candidiasis.

Hydrocortisone Acetate (1% w/w) is a low-potency (Class VII) topical corticosteroid on the WHO Model List of Essential Medicines. It represents the safest topical steroid for sensitive skin areas (face, intertriginous skin folds, groin) and pediatric patients, providing anti-inflammatory, anti-pruritic, and mild vasoconstrictive actions with minimal risk of skin thinning or systemic absorption. Indicated for mild eczema, facial dermatitis, intertrigo, insect bites, and anogenital pruritus.

Glycolic Acid (6%, 12% cream or face wash) is an alpha-hydroxy acid (AHA) derived from sugarcane. It weakens the cohesion of corneocytes in the lower stratum corneum, promoting gentle chemical exfoliation, stimulating dermal collagen synthesis, and accelerating cell turnover. Indicated for mild-to-moderate acne, photoaging, rough texture, post-acne hyperpigmentation, and keratosis pilaris.

Hydrocortisone Acetate (1% w/w) is a low-potency (Class VII) topical corticosteroid on the WHO Model List of Essential Medicines. It represents the safest topical steroid for sensitive skin areas (face, intertriginous skin folds, groin) and pediatric patients, providing anti-inflammatory, anti-pruritic, and mild vasoconstrictive actions with minimal risk of skin thinning or systemic absorption. Indicated for mild eczema, facial dermatitis, intertrigo, insect bites, and anogenital pruritus.

Metronidazole (1% ) + Povidone Iodine (5% ) Ointment is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Ozenoxacin Cream 1% is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Ozenoxacin Lotion 2% is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Povidone- Iodine Solution 10 % w/v is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Janaushadhi Suraksha Adhesive Bandages (Washproof) and Antiseptic Bandage Spray (Cetrimide 0.10% + Lidocaine 1.0%) is an essential first-aid wound dressing product on the PMBI Formulary. Suraksha strips feature an absorbent non-adherent wound pad impregnated with antiseptic, backed by a microperforated water-repellent adhesive film that protects cuts from water and dirt while allowing skin respiration. Antiseptic spray delivers instant surface local anesthesia and bactericidal protection with a quick-drying protective transparent film. Indicated for minor cuts, scrapes, abrasions, lacerations, and blister protection.

Benzoic acid 6% and Salicylic acid 3% Ointment is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Janaushadhi Burn Relief Spray (Lidocaine 3% and Benzethonium 0.20% Spray) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Calamine lotion (Zinc Oxide and Ferric Oxide with Aloe Vera and Light Liquid Paraffin) is a classic topical soothing astringent and antipruritic on the WHO Model List of Essential Medicines. It evaporates to cool the skin, while zinc oxide provides mild antiseptic and protective barrier coverage. Indicated for symptomatic relief of itching, insect bites, sunburn, chickenpox rash, poison ivy, and prickly heat.

Chloroxylenol 4.80% w/v + Terpineol 9% v/v + Absolute Alcohol 13.10% v/v Liquid is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Feracrylum (1% w/v gel, solution, mouthwash) is a polyacrylic biocompatible hemostatic and antimicrobial agent. It complexes with plasma proteins (specifically albumin) to form an artificial micro-thrombus barrier, stopping capillary oozing within minutes while exerting broad-spectrum bactericidal activity without tissue necrosis. Indicated for control of localized capillary bleeding, minor surgical wounds, burn dressing, oral mucositis, and antiseptic wound care.

Fluocinolone Acetonide / Fluocinonide is an intermediate-to-high potency fluorinated topical corticosteroid. It suppresses cutaneous inflammation and capillary permeability. Indicated for atopic dermatitis, severe contact dermatitis, and lichenified eczema.

Urea (10% w/w) and Lactic Acid (10% w/w) intensive footcare cream is an osmotic keratolytic and humectant formulation. Urea dissolves intercellular matrix proteins and attracts moisture into the stratum corneum, while lactic acid gently exfoliates thickened, calloused epidermis. Indicated for dry, rough, cracked heels, xerosis, calluses, and ichthyotic skin conditions.

Hydroquinone, Tretinoin, and Fluocinolone Acetonide is the gold-standard Triple Combination Cream (Kligman's formula) for refractory melasma. Hydroquinone (2-4%) competitively inhibits tyrosinase, blocking melanin pigment synthesis; Tretinoin (0.05%) accelerates epidermal turnover and keratinocyte shedding, facilitating hydroquinone penetration and dispersing melanin; and Fluocinolone Acetonide (0.01%), a mild-to-moderate topical corticosteroid, suppresses melanocyte inflammation and counteracts the irritant dermatitis of hydroquinone and tretinoin. Indicated for the short-term moderate-to-severe melasma of the face.

Hydroquinone, Tretinoin, and Fluocinolone Acetonide is the gold-standard Triple Combination Cream (Kligman's formula) for refractory melasma. Hydroquinone (2-4%) competitively inhibits tyrosinase, blocking melanin pigment synthesis; Tretinoin (0.05%) accelerates epidermal turnover and keratinocyte shedding, facilitating hydroquinone penetration and dispersing melanin; and Fluocinolone Acetonide (0.01%), a mild-to-moderate topical corticosteroid, suppresses melanocyte inflammation and counteracts the irritant dermatitis of hydroquinone and tretinoin. Indicated for the short-term moderate-to-severe melasma of the face.

Ketoconazole (2% w/v, alone or with Zinc Pyrithione 1%) is a topical imidazole broad-spectrum antifungal shampoo. It targets Malassezia furfur (Pityrosporum ovale), the lipophilic yeast implicated in seborrheic dermatitis and pityriasis capitis (dandruff), by inhibiting fungal ergosterol synthesis and reducing scalp scaling, erythema, and pruritus. Indicated for seborrheic dermatitis, stubborn dandruff, and pityriasis (tinea) versicolor of the scalp and trunk.

Mupirocin (2% w/w ointment) is a naturally derived antibiotic produced by Pseudomonas fluorescens on the WHO Model List of Essential Medicines. It reversibly binds specifically to bacterial isoleucyl-tRNA synthetase, completely arresting RNA and protein synthesis with zero cross-resistance to other antibiotic classes. Displays potent bactericidal activity against MRSA, MSSA, and Streptococcus pyogenes. Indicated for impetigo, traumatic skin lesions secondarily infected by S. aureus, and eradication of nasal MRSA carriage.

Nadifloxacin (1% w/w cream) is a synthetic broad-spectrum fluoroquinolone bactericidal antibacterial agent for topical dermatological use. It inhibits bacterial DNA gyrase (topoisomerase II), blocking bacterial DNA replication against Cutibacterium acnes, Staphylococcus epidermidis, and methicillin-resistant S. aureus (MRSA). Indicated for acne vulgaris, folliculitis, and superficial bacterial skin infections.

Naftifine Hydrochloride Cream 2% is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Povidone Iodine Spray 5% w/w is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Surgical Spirit (Methyl Salicylate 0.5% v/v + Diethyl Pthalate 2% v/v & Castor Oil 2.5% v/v) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Tofacitinib (2% w/w ointment) is a topical Janus kinase (JAK1/JAK3) inhibitor. It blocks intracellular JAK-STAT signaling pathways for multiple key inflammatory cytokines (IL-4, IL-13, IL-22, IL-31), rapidly reducing itch and clearing epidermal inflammation in inflammatory skin diseases without causing steroid-induced skin atrophy. Indicated for atopic dermatitis, alopecia areata, and plaque psoriasis.

Feracrylum (1% w/v gel, solution, mouthwash) is a polyacrylic biocompatible hemostatic and antimicrobial agent. It complexes with plasma proteins (specifically albumin) to form an artificial micro-thrombus barrier, stopping capillary oozing within minutes while exerting broad-spectrum bactericidal activity without tissue necrosis. Indicated for control of localized capillary bleeding, minor surgical wounds, burn dressing, oral mucositis, and antiseptic wound care.

Feracrylum (1% w/v gel, solution, mouthwash) is a polyacrylic biocompatible hemostatic and antimicrobial agent. It complexes with plasma proteins (specifically albumin) to form an artificial micro-thrombus barrier, stopping capillary oozing within minutes while exerting broad-spectrum bactericidal activity without tissue necrosis. Indicated for control of localized capillary bleeding, minor surgical wounds, burn dressing, oral mucositis, and antiseptic wound care.

Fluocinolone Acetonide / Fluocinonide is an intermediate-to-high potency fluorinated topical corticosteroid. It suppresses cutaneous inflammation and capillary permeability. Indicated for atopic dermatitis, severe contact dermatitis, and lichenified eczema.

Azelaic Acid (10%, 20% cream) is a naturally occurring saturated dicarboxylic acid anti-acne and anti-rosacea agent. It inhibits DNA synthesis in Cutibacterium acnes, suppresses follicular hyperkeratinization (comedolytic), and competitively inhibits tyrosinase, reducing post-inflammatory hyperpigmentation without bleaching normal skin. Indicated for mild-to-moderate inflammatory acne vulgaris, papulopustular rosacea, and post-inflammatory hyperpigmentation/melasma.

Benzoyl Peroxide (2.5%, 5% gel or soap) is a non-antibiotic topical anti-acne bactericidal agent on the WHO Model List of Essential Medicines. Upon application, it decomposes to release benzoic acid and reactive free oxygen radicals that oxidize bacterial proteins, rapidly destroying Cutibacterium acnes in the pilosebaceous follicle without inducing bacterial resistance. Also possesses mild comedolytic and keratolytic properties. Indicated for mild-to-moderate acne vulgaris.

Benzoyl Peroxide (2.5%, 5% gel or soap) is a non-antibiotic topical anti-acne bactericidal agent on the WHO Model List of Essential Medicines. Upon application, it decomposes to release benzoic acid and reactive free oxygen radicals that oxidize bacterial proteins, rapidly destroying Cutibacterium acnes in the pilosebaceous follicle without inducing bacterial resistance. Also possesses mild comedolytic and keratolytic properties. Indicated for mild-to-moderate acne vulgaris.

Glycolic Acid (6%, 12% cream or face wash) is an alpha-hydroxy acid (AHA) derived from sugarcane. It weakens the cohesion of corneocytes in the lower stratum corneum, promoting gentle chemical exfoliation, stimulating dermal collagen synthesis, and accelerating cell turnover. Indicated for mild-to-moderate acne, photoaging, rough texture, post-acne hyperpigmentation, and keratosis pilaris.

Glycolic Acid (6%, 12% cream or face wash) is an alpha-hydroxy acid (AHA) derived from sugarcane. It weakens the cohesion of corneocytes in the lower stratum corneum, promoting gentle chemical exfoliation, stimulating dermal collagen synthesis, and accelerating cell turnover. Indicated for mild-to-moderate acne, photoaging, rough texture, post-acne hyperpigmentation, and keratosis pilaris.

Halobetasol Propionate (0.05% w/w) is an ultra-high potency (Class I) fluorinated topical corticosteroid. It produces intense vasoconstriction, suppression of immune cell migration, and potent anti-inflammatory action in severe hyperkeratotic and inflammatory skin conditions. Indicated for plaque psoriasis and severe steroid-responsive dermatoses.